Literature DB >> 10658540

Prevalence and risk factors for latex allergy: a cross sectional study in a United Kingdom hospital.

J Smedley1, A Jury, H Bendall, A Frew, D Coggon.   

Abstract

OBJECTIVES: To determine the prevalence and risk factors for symptoms related to gloves, and the relation between symptoms and immunological evidence of type 1 hypersensitivity to latex in a United Kingdom health care setting.
METHODS: A cross sectional survey was carried out among 773 employees at a British hospital. A self administered questionnaire was used to collect information about symptoms related to gloves and associated risk factors in a sample of hospital staff who were likely to use gloves at work. All of those who reported symptoms suggestive of type 1 hypersensitivity were invited for skin prick testing and measurement of specific IgE to latex (RAST).
RESULTS: Among the 372 responders, symptoms related to gloves were common, 49% reported redness or itching of the hands, 14% reported urticaria, and 6% reported chest tightness. However, the frequency of positive skin prick tests and RASTs was surprisingly low (only two subjects tested positive).
CONCLUSIONS: These findings indicate the need for caution in the interpretation of symptoms related to gloves even when they seem to suggest type 1 hypersensitivity.

Entities:  

Mesh:

Year:  1999        PMID: 10658540      PMCID: PMC1757689          DOI: 10.1136/oem.56.12.833

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  19 in total

1.  Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves.

Authors:  R Arellano; J Bradley; G Sussman
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

2.  Contact urticaria and rhinitis from latex surgical gloves.

Authors:  T Carrillo; M Cuevas; T Muñoz; M Hinojosa; I Moneo
Journal:  Contact Dermatitis       Date:  1986-08       Impact factor: 6.600

3.  Rubber anaphylaxis.

Authors:  J E Slater
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

4.  Incidence of immediate allergy to latex gloves in hospital personnel.

Authors:  K Turjanmaa
Journal:  Contact Dermatitis       Date:  1987-11       Impact factor: 6.600

5.  Contact urticaria to rubber.

Authors:  A F Nutter
Journal:  Br J Dermatol       Date:  1979-11       Impact factor: 9.302

6.  Glove-induced dermal and respiratory symptoms among health care workers in one Finnish hospital.

Authors:  V M Kujala; K E Reijula
Journal:  Am J Ind Med       Date:  1995-07       Impact factor: 2.214

7.  Prevalence of occupational asthma due to latex among hospital personnel.

Authors:  O Vandenplas; J P Delwiche; G Evrard; P Aimont; X van der Brempt; J Jamart; L Delaunois
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

8.  Anaphylaxis associated with latex allergy during barium enema examinations.

Authors:  D R Ownby; M Tomlanovich; N Sammons; J McCullough
Journal:  AJR Am J Roentgenol       Date:  1991-05       Impact factor: 3.959

9.  Prevalence of natural rubber latex allergy (type I and type IV) in laboratory workers in The Netherlands.

Authors:  H de Groot; N W de Jong; E Duijster; R Gerth van Wijk; A Vermeulen; A W van Toorenenbergen; L Geursen; T van Joost
Journal:  Contact Dermatitis       Date:  1998-03       Impact factor: 6.600

10.  Occupational asthma due to latex surgical gloves.

Authors:  C Marcos; M Lázaro; J Fraj; S Quirce; B de la Hoz; M Fernández-Rivas; E Losada
Journal:  Ann Allergy       Date:  1991-09
View more
  3 in total

1.  Ethics in occupational health research.

Authors:  D Coggon
Journal:  Occup Environ Med       Date:  2001-10       Impact factor: 4.402

Review 2.  Latex allergy: review of recent advances.

Authors:  D A Levy; F Leynadier
Journal:  Curr Allergy Rep       Date:  2001-01

3.  Workers' compensation claims related to natural rubber latex gloves among Oregon healthcare employees from 1987-1998.

Authors:  Irwin B Horwitz; John Kammeyer-Mueller; Brian P McCall
Journal:  BMC Public Health       Date:  2002-09-18       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.